BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37096886)

  • 1. Triple Tumor Microenvironment-Responsive Ferroptosis Pathways Induced by Manganese-Based Imageable Nanoenzymes for Enhanced Breast Cancer Theranostics.
    He H; Du L; Xue H; An Y; Zeng K; Huang H; He Y; Zhang C; Wu J; Shuai X
    Small Methods; 2023 Jul; 7(7):e2300230. PubMed ID: 37096886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese molybdate nanodots with dual amplification of STING activation for "cycle" treatment of metalloimmunotherapy.
    Lei H; Li Q; Li G; Wang T; Lv X; Pei Z; Gao X; Yang N; Gong F; Yang Y; Hou G; Chen M; Ji J; Liu Z; Cheng L
    Bioact Mater; 2024 Jan; 31():53-62. PubMed ID: 37601278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrathin Clay Nanoparticles-Mediated Mutual Reinforcement of Ferroptosis and Cancer Immunotherapy.
    Liu J; Zhan J; Zhang Y; Huang L; Yang J; Feng J; Ding L; Shen Z; Chen X
    Adv Mater; 2024 Mar; 36(9):e2309562. PubMed ID: 37939375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese Coordination Micelles That Activate Stimulator of Interferon Genes and Capture In Situ Tumor Antigens for Cancer Metalloimmunotherapy.
    Li J; Ren H; Qiu Q; Yang X; Zhang J; Zhang C; Sun B; Lovell JF; Zhang Y
    ACS Nano; 2022 Oct; 16(10):16909-16923. PubMed ID: 36200692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsive manganese-based nanoplatform amplifying cGAS-STING activation for immunotherapy.
    He Q; Zheng R; Ma J; Zhao L; Shi Y; Qiu J
    Biomater Res; 2023 Apr; 27(1):29. PubMed ID: 37061706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP-Responsive Manganese-Based Bacterial Materials Synergistically Activate the cGAS-STING Pathway for Tumor Immunotherapy.
    Yang H; Yang S; Guo Q; Sheng J; Mao Z
    Adv Mater; 2024 Jun; 36(23):e2310189. PubMed ID: 38414097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic expression of cGAS in
    Waanders L; van der Donk LEH; Ates LS; Maaskant J; van Hamme JL; Eldering E; van Bruggen JAC; Rietveld JM; Bitter W; Geijtenbeek TBH; Kuijl CP
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy.
    Liang JL; Jin XK; Zhang SM; Huang QX; Ji P; Deng XC; Cheng SX; Chen WH; Zhang XZ
    Sci Bull (Beijing); 2023 Mar; 68(6):622-636. PubMed ID: 36914548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIR responsive nanoenzymes via photothermal ablation and hypoxia reversal to potentiate the STING-dependent innate antitumor immunity.
    Li Q; Yang M; Sun X; Wang Q; Yu B; Gong A; Zhang M; Du F
    Mater Today Bio; 2023 Apr; 19():100566. PubMed ID: 36816600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrazide/Metal/Indocyanine Green Coordinated Nanoplatform for Potentiating Reciprocal Ferroptosis and Immunity against Melanoma.
    Hou G; Qian J; Wang Y; Xu W; Guo M; Li Z; Wang J; Suo A
    ACS Appl Mater Interfaces; 2023 Aug; 15(31):37143-37156. PubMed ID: 37498789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer.
    Shen D; Luo J; Chen L; Ma W; Mao X; Zhang Y; Zheng J; Wang Y; Wan J; Wang S; Ouyang J; Yi H; Liu D; Huang W; Zhang W; Liu Z; McLeod HL; He Y
    Cancer Lett; 2022 Dec; 550():215919. PubMed ID: 36116741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING.
    Wang L; Luo R; Onyshchenko K; Rao X; Wang M; Menz B; Gaedicke S; Grosu AL; Firat E; Niedermann G
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37640480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manganese-Based Nanoactivator Optimizes Cancer Immunotherapy
    Hou L; Tian C; Yan Y; Zhang L; Zhang H; Zhang Z
    ACS Nano; 2020 Apr; 14(4):3927-3940. PubMed ID: 32298077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activatable Mn
    Liang Q; Chen J; Hou S; Li D; Zhu Y; Li R; Chen L; Li J; Fu W; Lei S; Zhang B; Zheng X; Zhang T; Duan H; He W; Ren J
    Biomaterials; 2023 Sep; 300():122206. PubMed ID: 37348325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
    Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
    Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
    Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
    J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-Modality Imaging-Guided Manganese-Based Nanotransformer for Enhanced Gas-Photothermal Therapy Combined Immunotherapeutic Strategy Against Triple-Negative Breast Cancer.
    Guan X; Zeng N; Zhao Y; Huang X; Lai S; Shen G; Zhang W; Wang N; Yao W; Guo Y; Yang R; Wang Z; Jiang X
    Small; 2024 May; 20(22):e2307961. PubMed ID: 38126911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-PD-L1 DNAzyme Loaded Photothermal Mn
    Liu P; Shi X; Peng Y; Hu J; Ding J; Zhou W
    Adv Healthc Mater; 2022 Apr; 11(8):e2102315. PubMed ID: 34841741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manganese suppresses the development of oral leukoplakia by activating the immune response.
    Shi Y; Su C; Ding T; Zhao H; Wang Y; Ren Y; Wu L; Zhang Q; Liang J; Sun S; Wang J; Li J; Zeng X
    Oral Dis; 2024 Mar; 30(2):462-476. PubMed ID: 36260219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.